Articles

Bonnie willett

Life Science Intelligence Case Study: Omnitheia 360-degree evidence generation and data consolidation for strategy consultancies.
Case Study: 360-Degree Evidence Generation and Intelligence Optimization for a Life Science Consultancy

The Challenge A life science strategy consultancy faced mounting inefficiencies due to fragmented intelligence gathering. Analysts spent excessive desk research hours manually aggregating data from multiple expensive BI subscriptions. Concurrently, their PMR was split between costly outsourced recruitment and time-intensive in-house efforts. Leadership mandated the use of AI to unify data sources, improve deliverable accuracy,…

View details
Case study title card: Accelerated Out-Licensing Strategy and Commercial Validation for a Phase 2 Biotech by Omnitheia.
Case Study: Accelerated Out-Licensing Strategy and Commercial Validation for a Phase 2 Biotech

The Challenge A Phase 2 biotechnology company needed to rapidly evaluate its competitive landscape to identify viable out-licensing partners for its lead asset. Relying on fragmented business intelligence subscriptions and siloed internal data left critical blind spots in their competitive intelligence, delaying the creation of a data-backed commercial partnering package. The Omnitheia Solution The client…

View details
Thumbnail for the Omnitheia Insight session with Renata Crome on bridging the biotech credibility gap.
The 10% Probability of Success: A Strategic Roadmap for Effective Drug Development and Market Launch

Contributors:Ajay Karandikar, Founder & CEO, OmnitheiaRenata Crome, Advisory Board, Omnitheia (Former Deputy Global Head, Roche) Reading Time: 6 minutes The Clinical Attrition Reality The pharmaceutical industry is currently defined by a significant paradox. While the average cost to develop a single drug has soared to $2.3 billion, the probability of success remains alarmingly low. Nine…

View details